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Introduction: Worldwide, regulatory issues related to the field of radiopharmacy are switching 
and turning each day more rigid. Due to these legal constraints and all the related economical 
consequences, the concept of large-scale radiopharmacies, that label and distribute 
radiopharmaceuticals in a ready-to-use form, disseminate widely and seem more and more 
attractive, even in usually less receptive countries. In such a context, issues as the appropriate 
choice for recipient/methodology (vial or syringe? Multi- or Monodoses?) as well as the 
adoption of distinct behaviors should be considered relevant.  
Aim: It is aimed to disseminate the results obtained on a large study performed to evaluate 
whether there is any correlation between factors as syringe volume, residence time and type 
of radiopharmaceutical with adsorbed fraction and stability.  
Material and Methods: The most widely used radiopharmaceuticals (99mTc-Tetrofosmin/99mTc-
Sestamibi, 99mTc-MAG3/99mTc-DTPA and 99mTc-MDP/99mTc-HDP) were labeled strictly according 
to manufacturer’s instructions. After radiolabelling, single-doses of each radiopharmaceutical 
were collected into 1 ml and 2 ml plastic syringes, from the same commercial brand  with 
increasing residence times on the syringes (0.5, 1, 2, 3 and 6 hours). The degree of adsorption 
to the syringes walls was determined after a real or simulated injection and the activity 
present at the empty syringes was recorded. Regarding radiochemical stability, the reference 
sample was the one withdrawn directly from the original vial and subsequent aliquots were 
tested for each time-point from the syringes immediately before radiopharmaceutical 
 
  
  
  
 
 
 
injection. Radiochemical purity was assessed by thin-layer chromatography, according to 
manufacturer’s or EU Pharmacopeia instructions.  
Student’s t-Test was used to evaluate differences between means from independent groups 
(stability on Syringe vs stability on Vial; adsorption on 1ml syringes vs adsorption of 2ml 
syringes) and Pearson’s Test to measure the association between adsorption and time of 
retention inside the syringe. 
Results: Adsorption to plastic material of syringes varies significantly depending on the 
radiopharmaceutical. As an example, it is presented here the retention fraction for the most 
frequent situation: 1 ml syringe and 30 minute residence time: 0.65% for 99mTc-MDP, 2.15% for 
99mTc-DTPA, 8.32% for 99mTc-MAG3 and 17.9% for 99mTc-tetrofosmin.  
Conclusion: Results demonstrate that adsorption of radiopharmaceuticals to plastic material 
of syringes should be a topic of concern on the daily practice as this can lead to misdiagnosis 
due to the administration of activities inferior to the ones needed to obtain good diagnostic 
information. This can have a major impact on Centralized Radiopharmacies, so special 
attention should be paid. 
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